Residential College | false |
Status | 已發表Published |
The factor structure of extrapyramidal symptoms evaluated using the Drug-Induced Extrapyramidal Symptoms Scale in patients with schizophrenia: Results from the 2016 REAP AP-4 study | |
Kubota, Chika1; Inada, Toshiya2; Lin, Shih Ku3; Avasthi, Ajit4; Chee, Kok Yoon5; Tanra, Andi Jayalangkara6; Yang, Shu Yu7; Chen, Lian Yu8,9,10; Chong, Mian Yoon11,12; Tripathi, Adarsh13; Kallivayalil, Roy Abraham14; Grover, Sandeep4; Park, Seon Cheol15; Kato, Takahiro A.16; Xiang, Yu Tao17; Sim, Kang18; Maramis, Margarita M.19; Noor, Isa Multazam20; Tan, Chay Hoon21; Sartorius, Norman22; Shinfuku, Naotaka23 | |
2022-12-03 | |
Source Publication | Human Psychopharmacology |
ISSN | 0885-6222 |
Volume | 38Issue:2Pages:e2861 |
Abstract | Introduction: Drug-induced extrapyramidal syndrome (EPS) remains a major problem in clinical psychiatry. This study aimed to examine the factor structure of drug-induced extrapyramidal symptoms observed in patients with schizophrenia and assessed using the Drug-Induced Extrapyramidal Symptoms Scale (DIEPSS). Methods: The participants were 1478 patients with a diagnosis of schizophrenia whose EPS was assessed using the DIEPSS in India, Indonesia, Japan, Malaysia, and Taiwan in the 2016 REAP AP-4 study. The records of the participants were randomly divided into two subgroups: the first for exploratory factor analysis of the eight DIEPSS items, and the second for confirmatory factor analysis. Results: The factor analysis identified three factors: F1 (gait and bradykinesia), F2 (muscle rigidity and tremor), and F3 (sialorrhea, akathisia, dystonia, and dyskinesia). Conclusion: The results suggest that the eight individual items of the DIEPSS could be composed of three different mechanisms: acute parkinsonism observed during action (F1), acute parkinsonism observed at rest (F2), and central dopaminergic mechanisms with pathophysiology other than acute parkinsonism (F3). |
Keyword | Antipsychotics Diepss Extrapyramidal Symptoms Schizophrenia |
DOI | 10.1002/hup.2861 |
URL | View the original |
Indexed By | SCIE |
Language | 英語English |
WOS Research Area | Neurosciences & Neurology ; Pharmacology & Pharmacy ; Psychiatry ; Psychology |
WOS Subject | Clinical Neurology ; Pharmacology & Pharmacy ; Psychiatrypsychology |
WOS ID | WOS:000920190500001 |
Publisher | WILEY, 111 RIVER ST, HOBOKEN 07030-5774, NJ |
Scopus ID | 2-s2.0-85143831632 |
Fulltext Access | |
Citation statistics | |
Document Type | Journal article |
Collection | DEPARTMENT OF PUBLIC HEALTH AND MEDICINAL ADMINISTRATION Faculty of Health Sciences |
Corresponding Author | Inada, Toshiya |
Affiliation | 1.Department of Psychiatry, National Center of Neurology and Psychiatry, Tokyo, Japan 2.Department of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan 3.Department of Psychiatry, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan 4.Department of Psychiatry, Post Graduate Institute of Medical Education and Research, Chandigarh, India 5.Tunku Abdul Rahman Institute of Neuroscience, Kuala Lumpur Hospital, Kuala Lumpur, Malaysia 6.Faculty of Medicine, Department of Psychiatry, Hasanuddin University, Makassar, Indonesia 7.Taipei City Hospital and Psychiatric Center, Taipei, Taiwan 8.Kunming Prevention and Control Center, Taipei City Hospital, Taipei, Taiwan 9.Institute of Epidemiology and Preventive Medicine, National Taiwan University, Taipei, Taiwan 10.Department of Forensic Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan 11.Health Management International, Singapore, Singapore 12.Regency Specialist Hospital, Johor, Malaysia 13.Department of Psychiatry, King George's Medical University, Chowk, India 14.Department of Psychiatry, Pushpagiri Institute of Medical Sciences and Research Centre, Thiruvalla, Kerala, India 15.Department of Psychiatry, Hanyang University Guri Hospital, Guri, South Korea 16.Department of Neuropsychiatry, Graduate School of Medicine, Kyushu University, Fukuoka, Japan 17.Unit of Psychiatry, Department of Public Health and Medicinal Administration, University of Macau, Macao 18.West Region. Institute of Mental Health, Singapore, Singapore 19.Department of Psychiatry, Airlangga University, Surabaya, Indonesia 20.Dr Soeharto Heerdjan Mental Hospital, Jakarta, Indonesia 21.Department of Pharmacology, National University of Singapore, Singapore, Singapore 22.Association for the Improvement of Mental Health Programmes, Geneva, Switzerland 23.International Center for Medical Research, Kobe University School of Medicine, Kobe, Japan |
Recommended Citation GB/T 7714 | Kubota, Chika,Inada, Toshiya,Lin, Shih Ku,et al. The factor structure of extrapyramidal symptoms evaluated using the Drug-Induced Extrapyramidal Symptoms Scale in patients with schizophrenia: Results from the 2016 REAP AP-4 study[J]. Human Psychopharmacology, 2022, 38(2), e2861. |
APA | Kubota, Chika., Inada, Toshiya., Lin, Shih Ku., Avasthi, Ajit., Chee, Kok Yoon., Tanra, Andi Jayalangkara., Yang, Shu Yu., Chen, Lian Yu., Chong, Mian Yoon., Tripathi, Adarsh., Kallivayalil, Roy Abraham., Grover, Sandeep., Park, Seon Cheol., Kato, Takahiro A.., Xiang, Yu Tao., Sim, Kang., Maramis, Margarita M.., Noor, Isa Multazam., Tan, Chay Hoon., ...& Shinfuku, Naotaka (2022). The factor structure of extrapyramidal symptoms evaluated using the Drug-Induced Extrapyramidal Symptoms Scale in patients with schizophrenia: Results from the 2016 REAP AP-4 study. Human Psychopharmacology, 38(2), e2861. |
MLA | Kubota, Chika,et al."The factor structure of extrapyramidal symptoms evaluated using the Drug-Induced Extrapyramidal Symptoms Scale in patients with schizophrenia: Results from the 2016 REAP AP-4 study".Human Psychopharmacology 38.2(2022):e2861. |
Files in This Item: | There are no files associated with this item. |
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment